Reframe Daily: New superbug-killer, diet-exercise cancer win, meditation rewires gaming addiction

Reframe Daily is where Christin Chong (neuroscience PhD, chaplain, healthtech strategy consultant) curates optimistic and credible healthtech news so you don’t have to.

Today in one sentence: A brand-new germ-killing medicine beat superbugs in mice, a two-day-a-week low-cal diet plus light weights slowed breast cancer, mindfulness meditation tamed gaming cravings and repaired brain wiring, a Thai probiotic lowered harmful blood toxins in kidney patients, and quick gene tests helped doctors pick anxiety pills with fewer side effects.

Christin’s note: found any of today’s news interesting and want to apply it to your life or help a loved one out? let’s talk about it in the reframe community!
Sign up here → https://forms.gle/tN3oabFTsDF21VnS8

Good news: Scientists created a brand-new antibiotic that kills many drug-resistant germs in mice and did not let them develop resistance.

Broad-spectrum antibiotic blocks superbugs with two targets

Market readiness: 🙂🙂 (animal studies show promise but human trials haven’t started) 

Good news: A small cancer trial found that combining an off-and-on “2-days-low-calorie” diet with light weight-training helped women on chemotherapy stay healthier and slowed their breast-cancer growth compared with exercise alone.

Intermittent energy-restriction plus resistance exercise lengthens progression-free survival in advanced breast cancer

Market readiness: 🙂🙂🙂 (phase-2 human data; needs bigger trials before routine care) 

Good news: Eight weeks of guided mindfulness meditation rewired brain networks and cut gaming cravings in people with internet-gaming disorder better than relaxation training.

Mindfulness meditation restores healthy brain connections in internet-gaming disorder

Market readiness: 🙂🙂🙂🙂🙂 (meditation is already accessible—study shows clear clinical benefit) 

Good news: A four-week study showed that a Thai strain of the probiotic Lacticaseibacillus rhamnosus lowered harmful uremic toxins and inflammation in people with chronic kidney disease who aren’t yet on dialysis.

Probiotic L. rhamnosus cuts uremic toxins in chronic kidney disease

Market readiness: 🙂🙂🙂🙂 (probiotic capsules exist, but larger trials are needed for CKD labeling) 

Good news: Giving doctors each patient’s drug-metabolism genes before prescribing anxiety medicine reduced side-effects and cut hospital visits in the first head-to-head test of pre-emptive pharmacogenomics for anxiety disorders.

Pre-emptive pharmacogenomic testing trims drug side-effects in anxiety patients

Market readiness: 🙂🙂🙂🙂 (clinical service is feasible now, but insurance coverage is limited)Thank you for taking the time to take care of yourself and your loved ones.